Clinical trial · Observational
Adaptation of an eHealth (Web-application) Platform for Delivery of a Sedentary Behavior Intervention Among Prostate Cancer Patients
NCT03740035CI-TRIAL-00057035terminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Pl left institution
Summary
Brief summary (as posted)
The overall objective of this study is to adapt and refine an existing eHealth (web-application/web-app/app) platform designed to promote spontaneous movement (reducing sedentary behavior) among older adults, to men with prostate cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Sedentary Lifestyle | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| eHealth for Sedentary Behavior | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Prostate Cancer Patients
- description
- Prostate cancer patients that who have been actively receiving care through Wake Forest Baptist Comprehensive Cancer Center and/or satellite clinics over the past two-year period will be using an eHealth for Sedentary Behavior.
- interventionNames
- Device: eHealth for Sedentary Behavior
Primary outcomes (3)
- measure
- Assessment of the design features and functionality of the web-app
- timeFrame
- 45 minutes
- description
- Participants will be given qualitative interviews on the functionality of the web-app. A thematic content analysis (TCA) for the evaluation of Think-Aloud and interview data will be used. Transcripts will be imported into ATLAS.ti software (Version 8, Berlin, Germany) and reviewed by the study team using an iterative approach.
- measure
- System Usability Scale
- timeFrame
- 30 minutes
Eligibility
Eligibility (as posted)
- Sex
- Male
Show eligibility criteria text
Inclusion Criteria: * Histologically confirmed prostate cancer. * Currently (in last 2-years) receiving care for prostate cancer at WFBMC. * Currently owns a smartphone or a tablet computer (iOS and major brand Android devices not including eReaders). * English-speaking. Exclusion Criteria: * Unable to provide informed consent (e.g., delirium). * Unable to ambulate safely (fall risk).
References
Publications (50)
- BACKGROUNDMiller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016 Jul;66(4):271-89. doi: 10.3322/caac.21349. Epub 2016 Jun 2. PMID 27253694
- BACKGROUNDChambers SK, Ng SK, Baade P, Aitken JF, Hyde MK, Wittert G, Frydenberg M, Dunn J. Trajectories of quality of life, life satisfaction, and psychological adjustment after prostate cancer. Psychooncology. 2017 Oct;26(10):1576-1585. doi: 10.1002/pon.4342. Epub 2017 Jan 11. PMID 27943512
- BACKGROUNDCheung AS, Zajac JD, Grossmann M. Muscle and bone effects of androgen deprivation therapy: current and emerging therapies. Endocr Relat Cancer. 2014 Oct;21(5):R371-94. doi: 10.1530/ERC-14-0172. Epub 2014 Jul 23. PMID 25056176
- BACKGROUNDAlibhai SM, Duong-Hua M, Cheung AM, Sutradhar R, Warde P, Fleshner NE, Paszat L. Fracture types and risk factors in men with prostate cancer on androgen deprivation therapy: a matched cohort study of 19,079 men. J Urol. 2010 Sep;184(3):918-23. doi: 10.1016/j.juro.2010.04.068. PMID 20643458
- BACKGROUNDPirl WF, Greer JA, Goode M, Smith MR. Prospective study of depression and fatigue in men with advanced prostate cancer receiving hormone therapy. Psychooncology. 2008 Feb;17(2):148-53. doi: 10.1002/pon.1206. PMID 17443645
- BACKGROUNDBylow K, Dale W, Mustian K, Stadler WM, Rodin M, Hall W, Lachs M, Mohile SG. Falls and physical performance deficits in older patients with prostate cancer undergoing androgen deprivation therapy. Urology. 2008 Aug;72(2):422-7. doi: 10.1016/j.urology.2008.03.032. Epub 2008 Jun 17. PMID 18561991
- BACKGROUNDDinh KT, Reznor G, Muralidhar V, Mahal BA, Nezolosky MD, Choueiri TK, Hoffman KE, Hu JC, Sweeney CJ, Trinh QD, Nguyen PL. Association of Androgen Deprivation Therapy With Depression in Localized Prostate Cancer. J Clin Oncol. 2016 Jun 1;34(16):1905-12. doi: 10.1200/JCO.2015.64.1969. Epub 2016 Apr 11.